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Recently, engineering the surface of nanotherapeutics with biologics to provide them with superior
biocompatibility and targeting towards pathological tissues has gained signiﬁcant popularity. Although
the functionalization of drug delivery vectors with cellular materials has been shown to provide syn-
thetic particles with unique biological properties, these approaches may have undesirable immunolog-
ical repercussions upon systemic administration. Herein, we comparatively analyzed unmodiﬁed
multistage nanovectors and particles functionalized with murine and human leukocyte cellular mem-
brane, dubbed Leukolike Vectors (LLV), and the immunological effects that may arise in vitro and in vivo.
Previously, LLV demonstrated an avoidance of opsonization and phagocytosis, in addition to superior
targeting of inﬂammation and prolonged circulation. In this work, we performed a comprehensive
evaluation of the importance of the source of cellular membrane in increasing their systemic tolerance
and minimizing an inﬂammatory response. Time-lapse microscopy revealed LLV developed using a
cellular coating derived from a murine (i.e., syngeneic) source resulted in an active avoidance of uptake
by macrophage cells. Additionally, LLV composed of a murine membrane were found to have decreased
uptake in the liver with no signiﬁcant effect on hepatic function. As biomimicry continues to develop,
this work demonstrates the necessity to consider the source of biological material in the development of
future drug delivery carriers.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Recent discoveries have demonstrated that biomimicry can be
employed to bestow synthetic carriers with surface modiﬁcations
derived from biological components, thereby providing robust
physiological tolerances and biological targeting [1e3]. In partic-
ular, our group previously demonstrated cellular membranes of
circulating leukocytes could be easily isolated and transferred ontoedicine, Houston Methodist
ouston, TX 77030, USA.
r Ltd. This is an open access articlethe surface of synthetic nanocarriers while maintaining key bio-
logical functions. These carriers, referred to as Leukolike Vectors
(LLV) [4], are composed of a loadable [5], biodegradable [6,7], and
biocompatible [8,9] multistage nanovector (MSV) [10e13] core
with a proteolipid outer shell puriﬁed from leukocyte cell mem-
brane (CM). This outer layer was shown to retain membrane pro-
teins [14] that are critical for increased adhesion towards inﬂamed
endothelium [15] while also providing prolonged circulation time
[16].
With the recent popularity of biomimetic delivery platforms,
the evaluation of carrier biocompatibility continues to remain a
major component for the successful translation into the clinic.
Nevertheless, current literature lacks a comprehensive analysis onunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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particular, systemic and cellular inﬂammation, as well as the
toxicity of isolated CM applied onto synthetic carriers are unknown,
regardless of various efforts to understand the working mechanism
of immune cells and their clinical potential. More so, despite
various sources demonstrating the clinical potential of syngeneic
(i.e., genetically compatible) leukocyte treatments for cancer, little
is known of the potential side effects a xenogeneic (i.e., genetically
incompatible) model may yield. In addition, a comparative analysis
of the potential side effects that can be caused by syngeneic and
xenogeneic membranes applied to a synthetic nanocarrier have not
previously been investigated. Herein, we performed a compre-
hensive study of the biological impact the source of membrane (i.e.,
murine and human) has when applied to MSV and compared to
uncoated particles, both in vitro and in vivo. Our ﬁndings indicate
the source of membrane is critical in inhibiting cellular internali-
zation and rapid clearance of the particles in vitro and in vivo,
respectively, although less so in triggering an acute inﬂammatory
response.
2. Materials and methods
2.1. Fabrication of Leukolike Vectors
MSV were fabricated as previously described using published
protocols [12]. Brieﬂy, hemispherical 3.2 mmMSVwith 15 nm pores
were washed in isopropyl alcohol (IPA). Oxidation of MSV was
performed by incubating particles in a 3:1 ratio of concentrated
sulfuric acid to 30% hydrogen peroxide. Reaction was allowed to
occur for 2 h with gradual heat being applied to bring the ﬁnal
temperature of the mixture to 90 C. Following heating, solution
was allowed to cool and MilliQ water was added to bring the
concentration of sulfuric acid to 10% and allowed to cool for an
additional 60 min with brief agitation. Particles were collected,
centrifuged at 4500  g, and washed three times with water. Next,
particles were washed three times in IPA and used as needed.
Amination of the surface with (3-aminopropyl)triethoxysilane
(APTES, Sigma) was performed by suspending particles in a 2%
APTES solution in IPA and incubated at 35 C while mixing at 1300
RPM. Next, aminated particles were dried under vacuum overnight
to polymerize the silane layer. Following polymerization, particles
were washed three times in IPA and ﬂuorescence-modiﬁcationwas
performed by incubating APTES-conjugated particles with
1 mg mL1 Alexa Fluor 555 NHS Ester (Life Technologies) resus-
pended in dimethyl sulfoxide for 2 h at room temperature under
brief mixing.
Fabrication of LLV was performed following previously estab-
lished protocols [4]. Brieﬂy, cellular membrane was extracted
following brief homogenization of cells in homogenization buffer
(250 mM sucrose, 10 mM Tris/HCl, 1 mM MgCl2, 1 mM KCl, 2 mM
phenylmethylsulfonyl ﬂuoride, trypsinechymotrypsin inhibitor
200 mg mL1, DNase 10 mg mL1, RNase 10 mg mL1; Sigma-
eAldrich). Following homogenization, lysed celled were carefully
layered onto a discontinuous sucrose gradient and centrifuged at
28,000 g for 30min at 4 C. Plasmamembranewas then collected
and added to a 150 mM sodium chloride solution. Next, MSV par-
ticles were conjugated with (3-aminopropyl)triethoxysilane
(APTES, Sigma) and, where stated, Alexa Fluor dyes (Invitrogen) as
previously described [17]. Particles were then incubated with the
proteolipid (i.e., Jurkat or J774 cell membrane extract) solution
overnight at 4 C under continuous rotation. Following incubation,
particles were centrifuged at 200  g for 10 min and washed twice
in 150 mM NaCl. Assessment of particle surface charge was ach-
ieved by suspending 1  106 particles into phosphate buffer (pH
7.4) solution and read using a Malvern ZetaSizer NanoZS. Unlessotherwise stated, experiments using MSV particles were previously
functionalized with APTES.
2.2. Time-lapse microscopy
The day before imaging, 2  104 J774 cells were seeded into a 4-
chamber slide (LabTek). DyLight 488-conjugated MSV, mLLV (con-
taining PE-FITC) and hLLV (containing PE-Rhod) were used. Parti-
cles were added at a particle:cell ratio of 1.5:1. TLM was performed
at HMRI Advanced Cellular and Tissue Microscope Core Facility
using a Spinning Disk Confocal microscope (Olympus) equipped
with an incubation chamber that maintained imaging conditions at
37 C and 5% CO2. Post-image analysis was performed by acquiring
images every 3 min or 5 min using a 40 objective for 2 h. At each
imaging point the DIC, FITC, and TRITC channels were collected and
analyzed with Slidebook software to generate movies. Each movie
was counted for free, associated, and internalized particles based
on their proximity to the membranes of macrophages. The number
of particles in each conditionwas counted at 15, 30, 60, 90, 120, and
150 min as well as the number of cells in the ﬁeld of view. The
percentage of particles was calculated by capping the maximum
number of particles (i.e., 100%) at 150 min and normalizing previ-
ous time points to this condition.
2.3. Western blot
For the analysis of NF-kB activation and autophagy, 3  105
J774 cells well1 were seeded into a 6 well plate. Following
overnight incubation, cell samples were treated with complete
media containing MSV (APTES), mLLV, hLLV, and LPS (1 mg mL1,
Sigma) (as positive control for NF-kB activation) in 2 mL well1.
Untreated cells represented the negative control. For the analysis
of NF-kB activation, the cells were harvested 1.5 h after treatment
to obtain nuclear or whole cell extracts and 24 h for autophagy.
Cell extracts containing nuclear soluble proteins and cytosolic
proteins were obtained using the Qproteome Nuclear Protein Kit
(Qiagen) while whole cell extracts were obtained using a RIPA
buffer (Thermo) with 1 mL Halt protease inhibitor cocktail
(Thermo) per 100 mL of buffer. 40 mg of whole cell extract, 20 mg of
cytosolic extract, or 10 mg of nuclear extract were loaded onto
SDS-PAGE and transferred to a PVDF membrane for Western blot
analysis. For the analysis of NF-kB activation, blots were incubated
with the following primary antibodies: anti-NF-kB p65 (1:200
dilution), anti-TBP (1:2000 dilution), anti-b-actin (1:2000 dilu-
tion) (Santa Cruz Biotechnology). For the analysis of autophagy,
blots were incubated with the following primary antibodies: anti-
LC3 (1:2000 dilution) and anti-GAPDH (1:20,000 dilution).
Following this incubation, membranes were then incubated with
horseradish peroxidase (HRP)-conjugated secondary antibodies.
Bands were visualized using a SuperSignal West Dura Chemilu-
minescent Substrate (Thermo) and images were acquired with
ChemiDoc XRSþ System and Image Lab software (Bio-Rad).
Quantitative analysis of the bands was performed using ImageJ
software (NIH).
2.4. Cytokine and plasma analysis
For the analysis of cytokines levels in vitro, J774 cells were
seeded at 5  104 cells well1 into a tissue-culture treated 96-well
plate and incubated overnight. Following incubation, cells were
treated with oxidized and APTES-modiﬁed MSV, mLLV, hLLV, and
zymosan (100 mg mL1, positive control) in complete media. Un-
treated cells represented a negative control. After 3 h and 24 h of
treatment, media from each sample was collected and centrifuged
at 10,000  g. The supernatant was then collected and analyzed for
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PLEX MAP Mouse Cytokine/Chemokine premixed Immunoassay
plate (Millipore).
Cytokines, hepatic, and renal function for in vivo experiments
were evaluated by collecting blood from treated BALB/c mice
(n¼ 3) and evaluated for cytokines asmentioned using aMILLIPLEX
MAP Mouse Cytokine/Chemokine premixed Immunoassay plate
(Millipore). Hepatic and renal functionwas evaluated by evaluating
blood serum for AST/ALT using an ALT Colorimetric Activity Assay
and AST Colorimetric Activity Assay (Sigma). Creatinine levels were
evaluated using a Creatinine Assay Kit (Abcam).
2.5. Intravital microscopy (IVM)
Live, wild-type BALB/c mice (Charles River) were imaged on an
upright Nikon A1R laser scanning confocal microscope adapted for
IVM [18]. Mice were anesthetized with isoﬂorane, surgically pre-
pared to expose the left lobe of the liver [19], and injected intra-
venously with a 40 kDa FITC-dextran tracer (1 mM, Invitrogen) to
delineate the vasculature [20]. Three days prior to imaging, mice
received a one-time intravenous injection of DiD-labeled autolo-
gous red blood cells (RBCs, ~3% hematocrit) [21]. High-resolution
time-lapse images of particle accumulation in the liver were ac-
quired acrossmultiple ﬁeld-of-views (FOVs) for up to 2 h at 10e30 s
intervals (30 fps) following a one-time intravenous injection of
0.5 108 particles in 50 ml PBS [19]. Particle accumulation dynamics
were quantiﬁed frame-by-frame using NIS Elements v4.1 [19].
Particle biodistribution was assessed 1 h after particle injection, at
which time the tissues harvested, sliced using a vibratome (Leica
VT-1000), and imaged using the IVM system. The cumulative par-
ticle density for each organ was quantiﬁed using at least 200
randomly selected ﬁeld-of-views (sized 4 mm  4 mm  3 mm)
using NIS Elements v4.1 [21]. All animal protocols were reviewed
and approved by the IACUC at Houston Methodist Research
Institute.
2.6. Histology
Tissue samples were obtained from wild-type BALB/c mice
(n ¼ 3) that were subjected to a one-time injection of 108 particles.
Organ samples were collected from liver, spleen, and lung at day 2
and day 7 for each variable group. Organs were placed in formalin
for 24 h before being transferred to a solution of 70% isopropyl
alcohol and then imbedded with formalin (10%). Next, sections
were deparaﬁnnized using xylene, rehydrated with decreasing
concentrations of alcohol, washed in water and stained with he-
matoxylin/eosin.
2.7. Statistical analysis
All results were collected and analyzed in triplicate and repre-
sented as a mean ± SD unless otherwise stated. All statistics were
calculated using Prism GraphPad software. NF-kB and LC3 statistics
were calculated using a student T-test. Cytokine expression, bio-
distribution, and in vivo cytokines were analyzed using a two-way
analysis of variance (ANOVA) followed by a Bonferroni post-test
comparing replicates means by rows.
3. Results and discussion
3.1. Synthesis and assembly of Leukolike Vectors
The synthesis of syngeneic (i.e., murine J774 macrophages,
mLLV) and xenogeneic (i.e., human Jurkat T lymphocytes, hLLV)
LLV was performed based on previously established techniques [4]for both in vitro and in vivo experiments. Brieﬂy, leukocytes were
collected, treated with an isotonic solution, and homogenized.
Following centrifugation by layering lysed cells on a discontin-
uous sucrose gradient, plasma membrane was recovered and
washed several times in a sodium chloride solution to remove
nucleic fragments [22]. The adjoining of puriﬁed membranes onto
the MSV surface was driven via electrostatic interactions between
positively charged (3-aminopropyl)triethoxysilane (APTES)-
modiﬁed MSV and negatively charged proteolipid membranes.
Zeta potential measurements revealed APTES-conjugation of
oxidized MSV resulted in a shift from 30.5 mV to þ8.53 mV [6,7].
Functionalization with murine-derived CM (mCM) resulted in a
drop of 18.44 mV from APTES MSV (þ8.53 mV) to mLLV
(9.91 mV), approaching values consistent with intact leukocyte
cells (20.56 mV) (Fig. 1a). A similar shift in values was observed
for LLV designed with human-derived CM (Fig. S1). Conﬁrmation
of a uniformly coated particle was assessed through scanning
electron microscopy (SEM) demonstrating the complete coverage
of the MSV pores following LLV assembly (Fig. 1b). Successful
glycoprotein retention and protein orientation was evaluated us-
ing a wheat germ agglutinin immunoﬂuorescence staining, spe-
ciﬁc to N-acetylglycosamine and sialic acid commonly found in
proteins on the cells surface (Fig. 1c). The intensity proﬁle of the
coating was assessed by comparing the ﬂuorescent signal of the
CM to the MSV core, revealing an overlap of the CM (red) with the
particles modiﬁed with ﬂuorescein isothiocyanate (green)
(Fig. 1d), validating the successful grafting of CM proteins onto the
MSV surface and conﬁrming previously published results [4].
Finally, western blot analysis of the LLV coating revealed the
presence of critical leukocyte markers for self-tolerance (i.e.,
CD45, CD47, MHC-1, Fig. 1e). This data aligns with previously
published results [4,14] and conﬁrms the reproducibility of our
assembly method as well as the presence of multiple leukocyte
surface biomarkers in the proper orientation on the surface of
MSV, including proteins that determine leukocyte bio-
compatibility and self-recognition.
3.2. Particleemacrophage interactions
The membrane coating was shown to be effective in inhibiting
particle internalization, however, whether this phenomenon was
an active inhibition of macrophage function or a cellular response
mediated by the surface contact with the particles was not previ-
ously demonstrated. Through time-lapse microscopy experiments,
we investigated the dynamics of this phenomenon by incubating
J774 macrophages with MSV (Supplemental movie 1), mLLV (Sup-
plemental movie 2), and hLLV (Supplemental movie 3) for
150 min at a ratio of 1.5:1 (particle:cell), in addition to macrophage
co-treated with mLLV and hLLV (Supplemental movie 4). An initial
analysis demonstrated J774 cells continuously patrol the sur-
rounding environment for materials to internalize and detect sur-
rounding particulates through surface interactions. Speciﬁcally, the
cells demonstrated interactions with all particle groups; however,
MSV and hLLV resulted with a ﬁrm interaction with the cells while
mLLV maintained an unstable interaction that often resulted in the
release of the particle following contact with the cell. This phe-
nomenon is clearly shown in Supplementary movies 1e3 and
snapshots depicted in Fig. 2a and Fig. S2. Quantitative analysis of
free and associated/internalized particles was performed by eval-
uating representative sections of videos obtained through live mi-
croscopy and assessed for particle interaction with cells.
Speciﬁcally, the fraction of free and interacting particles was
manually counted at 15, 30, 60, 90, 120, and 150 min with the
maximumparticle percentage being obtained at 150min (sufﬁcient
time to allow all particles to settle) and, as expected, the percentage
Fig. 1. Synthesis and assembly of Leukolike Vectors. (a) Bar graph comparing surface charge of particles before coating, after coating, and cells used to derive coating. (b) Scanning
electron micrographs of MSV before coating and after coating with cellular membrane with high magniﬁcation insets showing change in pore visibility, scale ¼ 1 mm,
insets ¼ 100 nm. (c) Confocal microscope image of particle (green) stained for WGA (red), scale ¼ 1 mm. (d) Intensity plot of confocal image representing uniform distribution of
WGA across particle. (e) Western blot analysis showing the presence of self-recognition proteins for whole cell lysate (WCL), LLV, and MSV. The data is plotted as a mean ± SD. (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 2. Interaction of macrophage with MSV and LLV coated with murine and human-derived cell membranes. (a) Time lapse images of J774 cells treated with MSV (red), mLLV
(orange), and hLLV (green) after 30, 60, 120, and 150 min, scale ¼ 20 mm. (b) Selected positions from time-lapse microscopy were carefully analyzed to distinguish free and
associated/internalized particles; one position was used for analysis for MSV, mLLV, and hLLV. (c) Scanning electron micrograph images of J774 cells after a 3 h treatment with MSV,
mLLV, and hLLV. Visible particles depicted by arrows, scale ¼ 10 mm. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of
this article.)
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nomenon was further validated with ﬂow cytometry and confocal
microscopy, demonstrating mLLV resulted in a signiﬁcant decrease
in cell internalization (Fig. S3). Deeper investigation performed
with SEM exhibited 3 h following treatment, macrophages exposed
with MSV and hLLV resulted in the formation of ﬁlopodia-like
structures, followed by particle internalization. Meanwhile, the
same interactions with mLLV resulted in a simple docking of the
particles on the cell surface (Fig. 2c). This data demonstrates the
presence of a surface coating does not change the overall interac-
tion with the cell, but can affect the internalization process.
Supplementary video related to this article can be found at
http://dx.doi.org/10.1016/j.biomaterials.2015.11.054.3.3. Cellular response upon treatment with LLV
The membrane coating applied on the particle surface may have
the potential to trigger a cellular response following macrophage
internalization ranging from inﬂammation, stress, and autopha-
gocytosis. In order to test this hypothesis, macrophages were
treated with unmodiﬁed MSV, mLLV, and hLLV at a 1:5 cell to
particle ratio. The release of IL-6 and TNF-a, cytokines critical in the
propagation of the inﬂammatory cascade [23], was measured after
3 and 24 h following treatment with zymosan, a molecule used to
induce inﬂammation [24], being employed as a positive control. In
all treatments, particles failed to trigger a signiﬁcant release of IL-6
or TNF-a at both 3 h and 24 h compared to untreated macrophages
while zymosan (i.e., positive control) displayed a signiﬁcant
elevation in both cytokines and at both time points (Fig. 3a). This
data indicates that neither the core, nor the source of the mem-
brane coating, was effective in increasing the level of inﬂammatory
biomarkers in vitro.
Additionally, macrophage interaction with foreign particulates
typically occurs through toll-like receptors whose signaling activate
the NF-kB pathway (i.e., effect on cellular stress [25,26], response to
reactive oxygen species [27] and foreign stimuli), thus activating
the transcription of cytokine/chemokine genes and other pro-
inﬂammatory pathways. Hence, to further evaluate the effect of
the source of membrane, we evaluated NF-kB activation following a
90 min treatment with particles using previously established pro-
tocols. Western blot analysis was used to detect the nuclear levels
of the p65/RelA subunit of NF-kB, typical assay performed to detect
the activation of this biomarker (Fig. 3b) [28]. MSV, mLLV, and hLLV
did not induce any signiﬁcant variation in the p65/RelA protein
expression, indicating that the contribution of a cellular coating to
MSV did not result in the activation of the NF-kB pathway. How-
ever, when treated with a positive control (i.e., lipopolysaccharide,
LPS), a signiﬁcant increase in NF-kB expression resulted, indicating
the source of the CM is not sufﬁcient in triggering stress events.
Furthermore, toll-like receptor signaling has also been shown to
induce autophagy [29] and, more recently, nanoparticles with
unique physiochemical characteristics have emerged as autophagy-
inducers [30]. To investigate the onset of autophagy in macro-
phages, we assessed the ratio of LC3-I to LC3-II, a common indicator
of autophagy [29,31,32], through western blot analysis following a
24 h treatment with particles (Fig. 3c). In this case, all treatment
groups were found to express signiﬁcantly elevated ratios of LC3-I/
LC3-II compared to untreated groups, however, no signiﬁcant dif-
ference was observed when compared to MSV. Furthermore,
although elevated levels of autophagy were witnessed among the
treatment groups, no signiﬁcant variations were observed for par-
ticles with a proteolipid shell, indicating that mLLV and hLLV
maintain similar safety in regards to MSV as previously reported
[6,9].3.4. Sequestration in MPS organs and biodistribution in vivo
Next, to evaluate the importance of the membrane source in
preventing sequestration by the mononuclear phagocyte system
(MPS) in vivo, we evaluated the accumulation kinetics of the par-
ticles in the primary ﬁltration organ of the MPS (i.e., liver). Our
results demonstrate that by measuring the real-time hepatic
accumulation over a period of 90 min using intravital microscopy
[4,17,33], a delay in particle hepatic accumulation was observed for
mLLV. BALB/c mice (i.e., strain fromwhich J774 cells were puriﬁed)
were administered a one-time co-injection of MSV/mLLV or MSV/
hLLV (Fig. 4). Both MSV and hLLV demonstrated rapid accumulation
in the liver following a logarithmic trend that plateaued at
approximately 5 min (Fig. 4a). On the other hand, mLLV displayed
delayed accumulation in the liver with sigmoidal characteristics
reaching comparable hepatic accumulation aftermore than 1 h. The
effect of a syngeneic CM coating in delaying particle clearance from
the circulation was further conﬁrmed by evaluating biodistribution
inmajorMPS organs ex vivo using confocal microscopy (Fig. 4b). For
all particles tested, the spleen, lung, and liver represented themajor
organs of accumulation, with minor accumulation detected in the
kidneys. More so, deposition of MSV and hLLV was found to be
similar for all organs with no signiﬁcance between the two while
mLLV exhibited a signiﬁcant decrease in lung accumulation and
signiﬁcantly higher blood circulation. Particle accumulation ratios
(i.e., liver:spleen:lung:blood) exhibited advantageous values for
mLLV at 1:4:1:1 compared to the higher values for MPS organs for
MSV and hLLV at 7:17:10:1 and 10:21:12:1, respectively. Surpris-
ingly, xenogeneic and mLLV displayed uniform distribution at the
liver as determined by longitudinal and transverse sectioning,
however, morphological differences were observed at the cellular
level. Speciﬁcally, internalized hLLV were predominately clustered
at the Kupffer cell centers, whereas mLLV were more widely spaced
and predominately found at the Kupffer cell periphery (Fig. 4c). This
data provides further insight into the membrane's potential to
delay sequestration of MSV and the importance of the membrane
source in delaying liver accumulation and prolonging circulation.
Additionally, this conﬁrms previous results obtained in vitro and
demonstrates the coating derived from a syngeneic source was not
only effective in increasing the circulation time of the particles but
it also reduced the overall accumulation of the particles in the
lungs.
3.5. Pathological implications in vivo
Next, the impact of membrane source on the MPS organ ultra-
structure was evaluated 2 and 7 days following particle adminis-
tration by examining hematoxylin and eosin stained tissues
sections from BALB/c mice (i.e., strain from which J774 cells were
puriﬁed). For pathological evaluation, a higher dose of particles was
injected (1  108 particles mouse1) compared to typical particle
administration [34] in an effort to exacerbate the potential for an
acute response. At 2 d, symptoms of increased pulmonary cellu-
larity and cell packing density were apparent for all treatments
compared to the untreated control (Fig. 5A). This effect was more
evident in lower magniﬁcation images revealing an effect extended
to the overall lung parenchyma (Fig. S4). Additionally, a substantial
amount of particles were found in the liver with cells displaying
empty cytoplasms, in addition to the formation of lymphatic cen-
ters (yellow dotted box). In spleen, no indication of stress was
apparent in any of the treatments despite particles being readily
visible at higher magniﬁcations (yellow arrows). This data exhibits
the lung as the principal organ to experience an adverse effect, with
no considerable difference between the different treatments.
Notably, 7 d following administration, lung thickness of the
M. Evangelopoulos et al. / Biomaterials 82 (2016) 168e177 173alveolar parenchyma was comparable to control mice demon-
strating reduced organ cellularity when compared to day 2 and
more evident in mLLV (Fig. 5B). Additionally, the liver and spleen of
treated groups displayed a return to normal cell morphology and a
decrease in particle retention, suggesting particle clearance or
degradation. These results reveal the side effects on organ ultra-
structure are mitigated by the system's ability to clear the particlesFig. 3. Cytokine expression and autophagy. (a) Cytokine expression 3 and 24 h following ad
LC3-I/LC3-II 3 h after particle administration and quantiﬁcation of NF-kB expression relativand/or degrade them. Furthermore, mLLV demonstrated superior
biocompatibility as witnessed by the reduced thickness of the
alveolar septa. To better understand the CM contribution to the
observed effects, a greater amount of CM than was used to coat the
particles was injected and organs were observed at 2 and 7 d.
Similar to the results obtained from MSV and LLV injections, an
increase in the thickness of the alveolar septa in the lungs wasministration of particles. (b) Western blot analysis of NF-kB p65 nuclear levels and (c)
e to TATA-binding protein. The data is plotted as a mean ± SD. *p < 0.05; ***p < 0.001.
Fig. 4. Sequestration of particles in vivo. (a) Time dependent accumulation of particles MSV, mLLV, and hLLV in liver of BALB/c mice measured using intravital microscopy. Data is
plotted as a mean curve ±1 SD. (b) Intravital data of particle distribution in organs harvested 60 min following injection, **p < 0.01, ***p < 0.001. (c) Distribution of MSV (blue) in
liver 90 min following simultaneous injection with mLLV or hLLV (red), (scale, 25 mm). High magniﬁcation images demonstrate internalization of particles at Kupffer cell centers
(green), scale ¼ 10 mm. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 5. Histological analysis. (A) Representative histological images of lung, liver, and spleen 2 days and (B) 7 days after treatment. Particles depicted by yellow arrows. (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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impact on the morphology of the cell cytoplasm, with a more
apparent effect for human-derived membrane (Fig. 4). Remarkably,
murine-derived membranes appeared to have no evident effect on
the liver while human-derived membranes displayed hepatocytes
with empty cytoplasm, indicating signs of stress. Additionally, no
long-term signs of stress were observed on the spleen with
symptoms displaying a transient effect that diminished after one
week, indicating a return to normal organ function. This data is
critical in demonstrating the potential effects themembrane source
can pose on organs of the MPS. Through pathological evaluation,
we demonstrate, for the ﬁrst time, that the addition of a membrane
coating on MSV results in a minimal acute response and has a more
pronounced effect only when themembrane source is derived from
a xenogeneic source. This data also provides further insight into the
membrane's potential to delay the sequestration of MSV and the
importance of the membrane source in delaying liver accumulation
and prolonging circulation. Additionally, this conﬁrms previous
results obtained in vitro and demonstrates the coating derived from
a syngeneic source was not only effective in increasing the circu-
lation time of the particles but also reducing the overall accumu-
lation in the lungs. Lastly, this data demonstrates the addition of a
proteolipid shell on the MSV results in comparable pathological
effects on major MPS organs as uncoated MSV.
3.6. Cytokine expression in vivo and systemic toxicity
To evaluate the inﬂammatory implications of our system in vivo,Fig. 6. Evaluation of plasmatic levels of cytokines and hepatic biomarkers of stress. Cytokine
(d) AST/ALT and (e) creatinine, 2 and 7 days following treatment with positive control, LPSthe blood of BALB/c mice was collected following treatment and
assessed for the presence of circulating soluble cytokines and bio-
markers speciﬁc for hepatic and renal function. Speciﬁcally, a panel
of ten cytokines was evaluated at 2 and 7 days following treatment
with particles and compared to the levels obtained 2 h following
LPS (i.e., positive control) administration. Interestingly, only inter-
feron gamma (IFNg), IL-2, and IL-3 displayed elevated cytokine
levels (Fig. 6) while IL-1a, IL-1b, IL-6, IL-10, IL-12, KC and TNF-a all
displayed signiﬁcantly lower values for particle treatments
compared to LPS (Fig. S5). Furthermore, initial values for IFNgwere
elevated for coated particles (i.e., syngeneic and xenogeneic) and
CM when compared to LPS, though 7 d following treatment, values
were consistent with untreated mice. Correspondingly, levels of IL-
2 and IL-3 were slightly elevated for particle groups, displaying a
statistically signiﬁcant difference among CM treatments, although
expression did not exceed that of LPS and matched untreated
groups at 7 d. This data demonstrates that while an initial immu-
nological response is observed for mLLV and hLLV, cytokine levels
return to healthy values one week following administration, indi-
cating a transient effect on cytokine expression. Additionally, an
evaluation of the aspartate transaminaseealanine transaminase
ratio revealed no signiﬁcant differences following mLLV adminis-
tration at both 2 and 7 d, while hLLV displayed a signiﬁcant
decrease compared to untreated controls, indicative of liver
dysfunction (Fig. 6d). Similarly, an assessment of creatinine levels,
an important indicator in renal function, revealed no signiﬁcant
difference between mLLV and untreated groups, while hLLV dis-
played a signiﬁcant decrease in creatinine levels even one weeklevels expressed in blood of BALB/c mice were evaluated for (a) IFNg, (b) IL-2, (c) IL-3,
shown at 2 h. The data is plotted as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001.
M. Evangelopoulos et al. / Biomaterials 82 (2016) 168e177176after particle administration (Fig. 6e). This demonstrates a favor-
able response when the membrane source is derived from a syn-
geneic source and exhibits undesirable characteristics for
xenogeneic material, particularly related to renal function.
4. Conclusion
Collectively, these ﬁndings suggest that mLLVwasmost effective
in delaying uptake by macrophages in vitro, likely due to the
presence of critical biomarkers and self-recognition receptors
preserved within the cellular coating. Additionally, the presence of
a membrane coating was not sufﬁcient in raising the expression of
inﬂammatory cytokines in vitrowhen compared toMSV and did not
induce autophagy. Notably, in vivo results demonstrated mLLV
resulted in prolonged circulation and delayed sequestration by the
liver, providing favorable delivery vector kinetics. An analysis of
critical MPS organs revealed all particle groups impacted the ul-
trastructure of the organs at day 2 with xenogeneic CM inducing
the most substantial effects, particularly to the lung and liver. This
effect on the organ ultrastructure was largely attributed to the
presence of both an MSV core and a membrane coating, however,
ultrastructure damage and particle accumulation greatly dimin-
ished one week following treatment, consistent with previous re-
ports [9]. Interestingly, cytokines involved in the activation of T
lymphocytes (i.e., IFNg, IL-2, IL-3) were found to be elevated 2 d
post treatment, though levels returned to healthy values at 7 d. This
initial cell-mediated immune response was likely due to an altered
surface composition of the LLV compared to leukocytes. Notably, in
this work we characterized, for the ﬁrst time, the in vitro and in vivo
impact of a biomimetic delivery systems assembled by coating a
nanoporous vehicle with syngeneic- or xenogeneic-derived CM.
Furthermore, this works highlights the importance of considering
the membrane source in the development of bio-inspired nano-
materials. In fact, a syngeneic-derived coating displayed favorable
properties in preventing internalization by the MPS in vitro and
in vivo, as well as favorable biocompatibility in comparison to un-
coated MSV and hLLV.
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